Navigation Links
Prescient Medical, Inc. to Present Data on Identification and Treatment of Rupture-Prone Coronary Plaques at EuroPCR 2008
Date:5/8/2008

Company Pursues Strategy of Reducing Heart Attack Deaths by Shielding

High-Risk Plaques in Coronary Arteries

DOYLESTOWN, Pa., May 8 /PRNewswire/ --- Prescient Medical, Inc., a privately held medical device company dedicated to reducing deaths from heart attacks, will present new experimental results on the chemical characterization and treatment of rupture-prone or "vulnerable" plaques, with a focus on the vPredict(TM) Optical Catheter System and the vProtect(TM) Luminal Shield, at the upcoming EuroPCR 2008 conference to be held in Barcelona, Spain from May 13 to 16.

The vProtect Luminal Shield was designed by Prescient Medical to treat soft, atherosclerotic lesions that may be at risk of rupture or that have recently ruptured. The self-expanding design of vProtect is a departure from the balloon-expandable stents that are mainstays of current focal treatment for coronary artery disease (CAD). The vProtect Luminal Shield has been designed to limit complications commonly associated with the insertion of stents, including vessel injury, restenosis, neointimal hyperplasia, and thrombosis.

The presentations will be an integral part of a session entitled "Glimpse Into The Future: Current Understanding of High-Risk Atherosclerosis Coronary Lesions," which will be held on May 14, 2008 from 13:30 to 16:50 in Room 5 of the conference. Professor Patrick Serruys, head of the Erasmus Medical Center's Department of Interventional Cardiology, will co-chair the session, which features presentations from leading authorities on coronary artery disease, including Dr. Guillermo Tearney, a distinguished researcher on the development and validation of new optical diagnostic technologies at Massachusetts General Hospital; and Dr. Juan Granada, Medical Director at the Jack H. Skirball Center for Cardiovascular Research. Dr. Tearney will present results from Prescient's vPredict Optical Catheter System in his presentation, "Spectroscopy Imagi
'/>"/>

SOURCE Prescient Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
3. Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results
4. Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results
5. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
6. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
7. Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM)
8. SBT Acquisition Inc. Successfully Completes Tender Offer for Shares of Lifecore Biomedical, Inc.
9. Tryton Medical, Inc. Closes $14 Million Financing
10. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
11. Cohera Medical, Inc. Announces Closing of Insider Round of Financing for Over $7.6 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Scientists at the Center for Learning and ... the California -based biopharmaceutical company Magceutics, ... for reversing memory decline in mice with Alzheimer,s Disease. ... improvement in advanced stage AD mice. The study is ... decline for advanced stage AD mice, and is also ...
(Date:5/16/2013)... Toronto, Canada (PRWEB) May 16, 2013 ... years and costs over one billion dollars. Despite this ... market. With stakes this high, is your clinical trial ... and deliver the best outcomes? , Dr. Frederic Sax, ... Quintiles, will discuss the use of data, information and ...
(Date:5/16/2013)... 16, 2013 Reportlinker.com announces ... is available in its catalogue: ... for Acute Coronary Syndromes - APAC ... http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic MediPoint: ... Syndromes - APAC Analysis and Market ...
(Date:5/16/2013)... DNA Genotek, a leading provider of products for ... program in conjunction with the African Society of Human Genetics ... reduce the cost of DNA collection for locally ... and Health in Africa (H3 Africa) Initiative and to facilitate ... the AfSHG is to build the capacity of ...
Breaking Biology Technology:Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8DNA Genotek Inc. Announces Spit for Africa Program 2DNA Genotek Inc. Announces Spit for Africa Program 3
... Application in the ... European Union, ... Food and Drug Administration (FDA) has approved the design of,a single, ... with chemotherapy as first-line,treatment in patients with non-small cell lung cancer ...
... the aim of a new licensing deal between the ... and the company, based in West Sacramento, Calif., have ... of jointly-owned intellectual property stemming from inventions both on ... enable manufacture of very thin, very small wires, films ...
... 16 Roche (OTCQX:,RHHBY; SWX: ROG.VX; RO.S), a world-leading ... has extended its,offer to acquire all of the outstanding ... ) to 5:00 p.m., New York City time on ... to expire at 5:00,p.m., New York City time, on ...
Cached Biology Technology:Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 2Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 3Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 4Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer 5Solar energy technology licensed 2Roche Extends Tender Offer for Ventana 2Roche Extends Tender Offer for Ventana 3Roche Extends Tender Offer for Ventana 4Roche Extends Tender Offer for Ventana 5
(Date:5/16/2013)... at sites outside the bone marrow in the ... in Munich now show that a specific type of ... cells. , Balanced hematopoiesis is essential for the function ... place mainly in the liver and the spleen. Later ... this tissue normally serves as the sole source of ...
(Date:5/16/2013)... Enang Abwe, a conservationist working in Cameroon and the ... has just been awarded the prestigious Whitley award. ... often called "The Green Oscars" because it celebrates the ... working in developing countries. Abwe was selected for ... and preserve Cameroon,s Ebo Forest and its wildlife inhabitants., ...
(Date:5/16/2013)... Germany , May 16, 2013 ... Value Enhancement Award on Tuesday to Germany,s ... its exceptional biometric border control system. DERMALOG ... with the Best Practices Award in the category Global ... its cutting edge Biometric   Border Control System ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4
... (highly active anti-retroviral therapy) has emerged as an extremely ... however, HAART can never truly eradicate the virus as ... chemical called suberoylanilide hydroxamic acid (SAHA), recently approved as ... on, latent HIV, making it an attractive candidate to ...
... MARCH 16, 2009--Throughout the world, nitrogen compounds are ... combustion of fossil fuels. These pollutants are deposited ... many hundreds of miles downwind of their release ... are a case in pointthough they contain little ...
... Researchers at the Johns Hopkins Bloomberg School of ... broiler poultry operations may contribute to the dispersion ... for human exposure to drug-resistant bacteria. The findings ... production and exposures to antibiotic resistant pathogens. Previous ...
Cached Biology News:Tree species composition influences nitrogen loss from forests 2Flies may spread drug-resistant bacteria from poultry operations 2
Recombinant Human CCL21/6Ckine (Mucin Stalk Chimera)...
Recombinant Human Erythropoietin (Tissue Culture Grade)...
Acrylamide PAGE 40% Solution, 1 l. Category: Electrophoresis Systems & Standards & Reagents, Electrophoresis Standards and Reagents, Gel Casting Chemicals....
Recombinant Mouse IL-23, CF...
Biology Products: